The Motley Fool Previous Page

3 Humongous Health-Care Stocks This Week

Keith Speights
October 26, 2012

Let's start with a caveat. Humongous is a relative word. We often see health-care stocks that skyrocket 15% or higher in one week. That didn't happen this week.

But in a week where the Dow, S&P 500, and Nasdaq indexes all fell, even strong single-digit returns in one week can be considered relatively humongous. With that said, let's look at three relatively humongous winners in the world of health care this week.

Perkin' up
Scientific instruments and services provider Perkin Elmer (NYSE: PKI  )  saw its shares jump more than most health-care stocks this week. The stock surged 9.5%, after the company released its quarterly results.

Revenues grew 13% compared to the same quarter last year. The strongest growth came from the company's Human Health segment. Revenue for the segment was $257 million, up 24% from the same quarter in 2011.

GAAP earnings were flat year-on-year, although adjusted earnings per share increased from $0.43 in third quarter of 2011, to $0.45 in 2012. Probably the best news was that Perkin Elmer raised its guidance for the year for adjusted earnings per share, to $2.05 to $2.07, from $2.00 to $2.05.  

Rumor has it
Another strong mover this week was Amarin (Nasdaq: AMRN  ) . Shares for the biopharmaceutical company increased 8.4%.

The only official news from the company this week related to two patents that were issued for Vascepa, Amarin's cholesterol drug. The stock didn't rise due to official news, though.

The real reason Amarin shot up s